KRISTEN WILSON: Open Payments
NPI 1831466747 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$806 in 39 payments from 15 companies in 2025. Trend: 2023 $1,591 · 2024 $2,442 · 2025 $806
Food & beverage: $806
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $148 |
| ABBVIE INC. | 7 | $112 |
| Celgene Corporation | 4 | $108 |
| Eisai Inc. | 4 | $91 |
| Merck Sharp & Dohme LLC | 3 | $80 |
| Janssen Biotech, Inc. | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $38 |
| PFIZER INC. | 2 | $35 |
| Geron Corporation | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $24 |
Products named: OPDUALAG, IMBRUVICA, Lenvima, KEYTRUDA, OPDIVO, REBLOZYL, RYBREVANT, FRUZAQLA.
Industry payments across SC — which companies pay providers there.
